The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is successfully treatable with pulmonary endarterectomy (PEA), balloon pulmonary angioplasty, and medical therapy. Registry to Evaluate Early and Long‐Term Pulmonary Arterial Hypertension Disease Management risk score (RRS) is able to pr...

Full description

Bibliographic Details
Main Authors: Pavel Jansa, Grzegorz Kopeć, Adam Torbicki, Roela Sadushi‐Kolici, Ioana‐Alexandra Campean, Michael Halank, Iveta Simkova, Regina Steringer‐Mascherbauer, Barbara Salobir, Walter Klepetko, Jaroslav Lindner, Irene M. Lang
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Pulmonary Circulation
Subjects:
chronic thromboembolic pulmonary hypertension
REVEAL risk score
treprostinil
Online Access:https://doi.org/10.1002/pul2.12274

Internet

https://doi.org/10.1002/pul2.12274

Similar Items